Biotechnology Value Fund L P's Form 4 filing
Merus N.V. (MRUS) · filed Jul 7, 2021
- Accession no.
- 0000921895-21-001818
- Filed
- Jul 7, 2021, 4:49 PM ET
- Trade date
- Jul 2, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $45.4M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Biotechnology Value Fund L PCIK 0000918923 | Other: See Explanation of Responses |
| BVF Partners L PCIK 0001055947 | 10% Owner |
| BVF IncCIK 0001056807 | 10% Owner |
| Biotechnology Value Fund II LPCIK 0001102444 | Other: See Explanation of Responses |
| Lampert Mark NCIK 0001233840 | 10% Owner |
| Biotechnology Value Trading Fund OS LPCIK 0001660683 | Other: See Explanation of Responses |
| BVF Partners OS Ltd.CIK 0001660684 | Other: See Explanation of Responses |
| BVF I GP LLCCIK 0001803805 | Other: See Explanation of Responses |
| BVF II GP LLCCIK 0001803806 | Other: See Explanation of Responses |
| BVF GP Holdings LLCCIK 0001803809 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 | Common Shares, (euro)0.09 nominal value per share | SSaleDisposed | −1,106,478 | $20.75 | −$22,959,418.5 | 2,696,674 | Direct | |
| Jul 2, 2021 | Common Shares, (euro)0.09 nominal value per share | SSaleDisposed | −928,739 | $20.75 | −$19,271,334.25 | 1,963,646 | Direct | |
| Jul 2, 2021 | Common Shares, (euro)0.09 nominal value per share | SSaleDisposed | −150,805 | $20.75 | −$3,129,203.75 | 311,210 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.